NeuroDerm (NDRM) Announces Successful Results in Using ND0612 as PD Treatment in Home Setting
Tweet Send to a Friend
NeuroDerm Ltd. (Nasdaq: NDRM) reported human factors data from a usability study focused on the interactions between Parkinson’s disease (PD) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE